Prefilled Syringes Market Overview:

The Global Prefilled Syringes Market was valued at $3,567 million in 2016, and is estimated to reach $7,212 million by 2023, registering a CAGR of 10.5% from 2017 to 2023. A “prefilled syringe” is a syringe filled with a fixed quantity of a therapeutic drug. These are novel devices used for delivering drugs with improved accuracy, affordability, efficacy, convenience, sterility, safety, and accessibility. These features make it more advantageous than traditional methods of drug delivery where glass or metal vials were used to store pharmaceutical drugs. The removal of drug from these vials was prone to contamination and increased the possibility of dosing errors. Therefore, prefilled syringes eliminate the aforementioned drawbacks, resulting in increase in their demand.

Get more information on this report: Request Sample Pages

The global prefilled syringes market is segmented based on material, design, therapeutic, application, and geography. Based on material, it is bifurcated into glass-based and plastic-based. Based on design, it is divided into single-chamber prefilled syringes, dual-chamber prefilled syringes, and customized prefilled syringes. Based on therapeutic, it is categorized into large molecules and small molecules. Based on application, the market is classified into anaphylaxis, rheumatoid arthritis, diabetes, and others (cancer, multiple sclerosis). Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Get more information on this report: Request Sample Pages

Drivers, Restraints, and Opportunities

The impact of the driving factors is expected to surpass the effect of restraints. Moreover, the technological advancements leading to higher adoption rate and untapped markets in the developing countries are expected to provide new avenues for the growth of prefilled syringes market in the near future.

Get more information on this report: Request Sample Pages

Global Prefilled Syringes Market: Key Geographic Segment

Europe accounted for the highest market share in the industry in 2016, and is expected to maintain its dominance throughout the forecast period.

The key players operating in the global prefilled syringes market include Becton, Dickinson and Company, Medtronic plc., Gerresheimer AG, Terumo Medical Corporation, West Pharmaceutical Services, Inc., Nipro Corporation, Unilife Corporation, Vetter Pharma International GmbH, Baxter International, and Abbott Laboratories.

The other prominent players in the value chain include Ypsomed Holding AG, Haselmeier, Weigao Group, Owen Mumford, Bayer Healthcare, and Biocon.

Key Benefits

This report entails a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.

Market estimations are based on comprehensive analysis of the key developments in the industry.

The global market is comprehensively analyzed with respect to material, design, therapeutic, application, and geography.

In-depth analysis based on geography assists to understand the regional market to assist in strategic business planning.

The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

Prefilled Syringes Market Key Segments:

By Material

Glass-based

Plastic-based

By Design

Single-chamber Prefilled Syringes

Dual-chamber Prefilled Syringes

Customized Prefilled Syringes

By Therapeutic

Large Molecules

Small Molecules

By Application

Anaphylaxis

Rheumatoid Arthritis

Diabetes

Others (Cancer, Multiple Sclerosis, and others)

By Geography